The pharmaceutical industry tends to perform relatively well amid recessionary pressures, as it enjoys inelastic demand for its products and services. So, investors looking for quality pharma stocks can consider buying Ironwood Pharmaceuticals, Inc. (IRWD) and Calliditas Therapeutics AB (publ) (CALT).
According to U.S. pharmaceutical industry statistics, the U.S. will have a 43.72% market share in the global pharma industry in 2023. Also, the U.S. is expected to spend $605 to 635 billion on medicine by 2025.
